Freeze-Dried Hemostatic for Healthcare Professionals - Medical / Health Care - Clinical Services
One of the biggest challenges in clinical trials is recruiting volunteers. Often, the challenge lies in the ability to educate patients. Understanding the potential benefits and risks of participating in a clinical trial can be overwhelming. As a healthcare provider, you can help patients navigate the pros and cons and the questions they may have about clinical trials. With your help, patients can better decide what is the best course for their individual situation.
Cellphire is committed to developing and obtaining regulatory approvals for next generation therapies to improve and save the lives of patients.
All investigational therapies or drugs must go through clinical trials and be approved by a regulatory body such as the U.S. Food and Drug Administration. In most cases, the only way patients can access investigational new drugs is to participate in clinical trials.
However, we understand there may be situations where seriously ill patients may not be eligible or able to participate in a clinical trial. Expanded Access Programs may provide investigational therapies to a limited group of people who are not eligible or able to participate in a clinical trial—but who have a serious or life-threatening disease for which their physician has determined there are no appropriate treatment options.
Cellphire has developed an Individual Patient Expanded Access Policy for Thrombosomes to address the needs of individual patients who may not have access to clinical trials.